328 related articles for article (PubMed ID: 2148615)
1. [Prophylaxis of malaria].
Charmot G; Coulaud JP
Presse Med; 1990 Dec 22-29; 19(44):2026-30. PubMed ID: 2148615
[TBL] [Abstract][Full Text] [Related]
2. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
[TBL] [Abstract][Full Text] [Related]
3. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
[TBL] [Abstract][Full Text] [Related]
4. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Boudreau EF; Pang LW; Chaikummao S; Witayarut C
Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
[TBL] [Abstract][Full Text] [Related]
5. [Malaria chemoprophylaxis. Resistance problems].
Danis M; Gentilini M
Arch Fr Pediatr; 1985 Dec; 42 Suppl 2():971-5. PubMed ID: 3914247
[TBL] [Abstract][Full Text] [Related]
6. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M
JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409
[TBL] [Abstract][Full Text] [Related]
7. [The proper use of antimalarial drugs currently available].
Bourgeade A; Delmont J
Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
[TBL] [Abstract][Full Text] [Related]
8. The Italian army standpoint on malaria chemoprophylaxis.
Peragallo MS
Med Trop (Mars); 2001; 61(1):59-62. PubMed ID: 11584658
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
[TBL] [Abstract][Full Text] [Related]
10. [Chemoprophylaxis of malaria in travelers to endemic zones].
de Górgolas Hernández-Mora M; Blanco García A; Martín Torres MP; Fernández Guerrero ML
Rev Clin Esp; 1998 Jun; 198(6):364-8. PubMed ID: 9691743
[No Abstract] [Full Text] [Related]
11. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.
Steffen R; Fuchs E; Schildknecht J; Naef U; Funk M; Schlagenhauf P; Phillips-Howard P; Nevill C; Stürchler D
Lancet; 1993 May; 341(8856):1299-303. PubMed ID: 8098447
[TBL] [Abstract][Full Text] [Related]
12. Malaria prophylaxis in travellers to tropical Africa.
Weinke T; Weber G; Schultes U; Hopfenmüller W; Janitschke K
Klin Wochenschr; 1990 Mar; 68(5):277-80. PubMed ID: 2182940
[TBL] [Abstract][Full Text] [Related]
13. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
[TBL] [Abstract][Full Text] [Related]
14. Tolerance of mefloquine alone and in combination with sulfadoxine-pyrimethamine in the prophylaxis of malaria.
Reisinger EC; Horstmann RD; Dietrich M
Trans R Soc Trop Med Hyg; 1989; 83(4):474-7. PubMed ID: 2694482
[TBL] [Abstract][Full Text] [Related]
15. [Malaria--chemoprophylaxis 2001].
Hatz FR; Beck B; Blum J; Funk M; Furrer H; Genton B; Holzer B; Loutan L; Markwalder K; Raeber PA; Schlagenhauf P; Siegl G; Steffen R; Stürchler D; Wyss R
Ther Umsch; 2001 Jun; 58(6):347-51. PubMed ID: 11441694
[TBL] [Abstract][Full Text] [Related]
16. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
[TBL] [Abstract][Full Text] [Related]
17. Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.
Fogh S; Schapira A; Bygbjerg IC; Jepsen S; Mordhorst CH; Kuijlen K; Ravn P; Rønn A; Gøtzsche PC
Br Med J (Clin Res Ed); 1988 Mar; 296(6625):820-2. PubMed ID: 3130927
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
19. Update on prevention of malaria for travelers.
Lobel HO; Kozarsky PE
JAMA; 1997 Dec; 278(21):1767-71. PubMed ID: 9388154
[TBL] [Abstract][Full Text] [Related]
20. The effect of chemoprophylaxis on the timing of onset of falciparum malaria.
Reyburn H; Behrens RH; Warhurst D; Bradley D
Trop Med Int Health; 1998 Apr; 3(4):281-5. PubMed ID: 9623928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
